The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-24), Tandem Diabetes Care's share price is $34.92. Tandem Diabetes Care's Book Value per Share for the quarter that ended in Dec. 2023 was $4.78. Hence, Tandem Diabetes Care's PB Ratio of today is 7.30.
The historical rank and industry rank for Tandem Diabetes Care's PB Ratio or its related term are showing as below:
TNDM'
s PB Ratio Range Over the Past 10 Years
Min: 2.96 Med: 8.67 Max: 97.4
Current: 7.31
During the past 13 years, Tandem Diabetes Care's highest PB Ratio was 97.40. The lowest was 2.96. And the median was 8.67.
TNDM's PB Ratio is ranked worse than 88.69% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 2.21
vs TNDM: 7.31
During the past 12 months, Tandem Diabetes Care's average Book Value Per Share Growth Rate was -29.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -6.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 18.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Tandem Diabetes Care was 43.80% per year. The lowest was -52.30% per year. And the median was 10.50% per year.
Back to Basics: PB Ratio
Tandem Diabetes Care PB Ratio Historical Data
The historical data trend for Tandem Diabetes Care's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Tandem Diabetes Care's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tandem Diabetes Care PB Ratio Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Tandem Diabetes Care's PB Ratio distribution charts can be found below:
* The bar in red indicates where Tandem Diabetes Care's PB Ratio falls into.
Tandem Diabetes Care PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Tandem Diabetes Care's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Tandem Diabetes Care (NAS:TNDM) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Tandem Diabetes Care PB Ratio Related Terms
Thank you for viewing the detailed overview of Tandem Diabetes Care's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Tandem Diabetes Care (Tandem Diabetes Care) Business Description
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. Nearly three quarters of total revenue is derived from the U.S., with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TNDM has been successfully added to your 